4.6 Review

Examining the Comorbidity Between Attention Deficit Hyperactivity Disorder and Bipolar I Disorder: A Meta-Analysis of Family Genetic Studies

Journal

AMERICAN JOURNAL OF PSYCHIATRY
Volume 169, Issue 12, Pages 1256-1266

Publisher

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.2012.12010087

Keywords

-

Categories

Funding

  1. Alcobra
  2. Shire
  3. NIH
  4. Eli Lilly
  5. Janssen
  6. McNeil
  7. Novartis
  8. Pfizer
  9. Elminda
  10. Fundacion Areces
  11. Medice Pharmaceuticals
  12. Spanish Child Psychiatry Association
  13. Abbott
  14. Alza
  15. AstraZeneca
  16. Bristol-Myers Squibb
  17. Celltech
  18. Cephalon
  19. Esai
  20. Forest
  21. GlaxoSmithKline
  22. Gliatech
  23. Merck
  24. NARSAD
  25. National Institute on Drug Abuse
  26. New River
  27. National Institute of Child Health and Human Development
  28. NIMH
  29. Noven
  30. Neurosearch
  31. Organon
  32. Otsuka
  33. Pharmacia
  34. Prechter Foundation
  35. Stanley Foundation
  36. UCB Pharma
  37. Wyeth
  38. Primedia/Massachusetts General Hospital Psychiatry Academy
  39. Boehringer-Ingelheim
  40. Sepracor
  41. UCB (Schwarz) Pharma

Ask authors/readers for more resources

Objective: The existence of comorbidity between attention deficit hyperactivity disorder (ADHD) and bipolar I disorder has been documented in clinical and epidemiological studies, in studies of children and adults, and in diagnosed ADHD and bipolar I patient samples. Yet questions remain about the validity of diagnosing bipolar I disorder in ADHD youth. The authors aim to clarify these issues by reviewing family genetic studies of ADHD and bipolar I disorder. Method: The authors applied random-effects meta-analysis to family genetic studies of ADHD and bipolar I disorder. Twenty bipolar proband studies provided 37 estimates of the prevalence of ADHD in 4,301 relatives of bipolar probands and 1,937 relatives of comparison probands. Seven ADHD proband studies provided 12 estimates of the prevalence of bipolar I disorder in 1,877 relatives of ADHD probands and 1,601 relatives of comparison probands. Results: These studies found a significantly higher prevalence of ADHD among relatives of bipolar probands and a significantly higher prevalence of bipolar I disorder among relatives of ADHD probands. These results could not be accounted for by publication biases, unusual results from any one observation, sample characteristics, or study design features. The authors found no evidence of heterogeneity in the ADHD or bipolar family studies. Conclusions: The results suggest that ADHD plus bipolar comorbidity cannot be accounted for by misdiagnoses, but additional research is needed to rule out artifactual sources of comorbidity. More research is also needed to determine whether comorbidity of ADHD and bipolar I disorder constitutes a familial subtype distinct from its constituent disorders, which if confirmed would have implications for diagnostic nosology and genetic studies. (Am J Psychiatry 2012; 169:1256-1266)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available